Aarti Pharmalabs Limited has announced the resignation of Shri G.M. Naidu, who held the position of Manufacturing/ Sr. General Manager. He will be relieved from his duties effective from the closure of business hours on August 31, 2026. The resignation is due to personal commitments. The company has provided detailed information regarding this cessation of senior management personnel as required by listing regulations.
Senior Management Change at Aarti Pharmalabs
Aarti Pharmalabs Limited has formally notified the stock exchanges regarding the resignation of a key senior management personnel. Shri G.M. Naidu, holding the dual role of Manufacturing and Sr. General Manager, has tendered his resignation. The company confirmed that Shri Naidu will be relieved from his services on August 31, 2026, following the close of business hours on that date.
Reason for Cessation
The company’s filing indicates that Shri G.M. Naidu’s resignation is prompted by his personal commitments. This event is being communicated in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The resignation intimation was received by the company on June 10, 2026.
Details Provided
In compliance with the disclosure requirements, Aarti Pharmalabs has provided specific details concerning this change. The announcement includes Shri G.M. Naidu’s name and the reason for his departure, citing it as a resignation from his position as Manufacturing/ Sr. General Manager due to personal commitments. The date of cessation is confirmed as August 31, 2026. Further details, as mandated by the Listing Regulations, are enclosed in Annexure A.
The information is also available on the company’s official website, www.aartipharmalabs.com, for public access.
Source: BSE
